NCT00429507 - Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Breast CancerBone Metastases

Interventions

DRUG

153 Sm-EDTMP

Tracer dose = 30 mCi by vein On Day 1. If enough study drug goes to bones, will receive a higher dose of 153 Sm-EDTMP, called a therapy dose, 7-14 days after the tracer dose.

BEHAVIORAL

Questionnaire

Questionnaires taking about 15 minutes to complete.

PROCEDURE

Stem Cell Transplant

Stem Cell Transplant on Day 0, about 14-21 days after Samarium 153-EDTMP.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston